Closing on Nov. 17: Investor Calendar + Company Spotlight

INVESTOR NETWORK is the go-to, one-stop site for shareholders, clients and prospective investors

Cephalon, Inc.

Cephalon, Inc.

Sector: Pharmaceutical Preparations Region: PA, United States

: | US Composite: CEPH

Cephalon, Inc. is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. It manufactures medicate products in four therapeutic areas: Central Nervous System, Pain, Inflammatory Diseases and Oncology. Cephalon's products include NUVIGIL, TREANDA, AMRIX, FENTORA, PROVIGIL, TRISENOX, GABITRIL and ACTIQ. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.

× We're Sorry! We do not have an investor kit available for this company. Tell us you want one!

News & Analysis